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 Compared to the rest of the world Sub-Saharan Africa (SSA) still has 
a challenge in reducing its adult mortality. Investments in adult health is a 
prerogative of SSA governments as they provide the source of labour force, 
human capital endowment and consumption which are benchmarks of 
economic growth. Though health expenditure has risen in SSA, quality of 
governance especially level of corruption is not impressive. The corruption 
levels are of concern because they may have a negative impact on 
effectiveness of health expenditure in reducing premature adult mortality in 
SSA. This study examines interaction of health expenditure and corruption 
and its effect on adult mortality. Regional differences in the relationship 
between health expenditure, corruption and adult mortality are also 
determined across the four regions of SSA: Western, Southern, Central and 
Eastern Africa. This study has used dynamic panel data model to investigate 
effectiveness of health expenditure on adult mortality under the influence of 
corruption. The results indicate that corruption influence positively the 
effectiveness of public health expenditure while that of private health 
expenditure is negative. Regional variation exists in the effectiveness of both 
public and private health expenditure on adult mortality.  
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Background 
 Human capital is widely believed to enhance economic growth 
(Lucas, 1988; Romer, 1990; Mankiw, et al. 1992). This implies that 
economies are likely to benefit from investment in education, training and 
health (Hanushek and Kim, 1995; Bloom and Canning, 2000; 2003) as 
sources of human capital.  Africa’s human capital base is threatened by 
major health problems facing adults. These health problems include 
HIV/AIDS, tuberculosis, malaria and maternal child birth risks (Institute for 
Health Metrics and Evaluation et al., 2013). The result is premature 
mortality, loss of human capital and output. In the period 1990-2010, 
HIV/AIDS led to a rise in healthy years (disability free life) loss by about 
328% despite a decline of 22% in the period 2005-2010 (Institute for Health 
Metrics and Evaluation et al., 2013). The trends in the adult mortality are 
shown in Table 1.  Adult mortality rates have been declining since 1995 all 
over the world. However, adult mortality rates increased in some countries in 
the period 2000-2005. This may be attributed to HIV/AIDS pandemic which 
peaked during this period (UNAIDS, 2006). Subsequently with exception of 
South Africa and Mozambique adult mortality rates declined in 2005-2010. 
 The decline in adult mortality rates in SSA may be attributed to two 
factors. First, commitments by SSA governments and development partners 
increased. This is evidenced by the initiatives for better health during the 
previous decade and half. The initiatives include Global Fund for HIV/AIDS, 
Malaria and Tuberculosis (Global Fund, 2013), PEPFAR (PEPFAR, 2013), 
Abuja Declaration on public health expenditure by AU head of states (OAU, 
2001) and the Millenium Development Goals (MDGs). The MDGs on adult 
health focused on: reduction of maternal mortality by the three-quarters over 
the period 1990 to 2015; and combating HIV/AIDS, Malaria and, other 
diseases by 2015 (UN, 2000). Between 1990 and 2008 the maternal mortality 
rate in SSA decreased by about 230 per 100,000 live births (from 870 in 
1990 to 640 in 2008) (United Nations, 2011). Nevertheless, the rate is far 
below the targeted 218 per 100,000 live births by 2015 (UN, 2000).  
HIV/AIDS related deaths declined worldwide by 19% between 2004 and 
2009. One of the reasons is that the number of people on anti-retroviral 
therapy increased 13 times over this period (United Nations, 2011). As 
HIV/AIDS related deaths fell the number of people living with HIV/AIDS 
increased since 1990 while, the number of people infected with HIV/AIDS 
decreased since 2005 (ibid.).  
 The second factor that may have contributed to the decline in adult 
mortality rates in SSA is increased spending on health. Public health 
spending as a percentage of government expenditure increased from an 
average of 0.9% in 2000 to 9.8% in 2011 (World Health Organization, 
2013). SSA also benefitted from the Global Fund grant of about US$ 2.64 
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billion towards improving health quality all over the world especially in the 
developing countries. Through this grant; by 2011 about 3.3 million HIV 
patients were on antiretroviral (ARV) treatment; about 8.6 million people 
were on tuberculosis treatment; and more than 230 million insecticide treated 
nets were distributed to malaria endemic zones (Global Fund, 2011).  Other 
factors that may have led to  reduction in adult mortality rates are; economic 
growth, increase in literacy  and better quality of governance in most parts of 
the world (Brenner, 2005; Cutler et al., 2006; Lleras-Muney, 2004; Clark and 
Royer, 2010; Montez et al., 2012). 
 Despite the decline in adult mortality rates worldwide, Sub-Saharan 
Africa recorded the highest adult mortality (Table 1). In the period 2005-
2010 it averaged 383 per 1000 adults, more than three times that of North 
America and Oceania. It was more than double, the average adult mortality 
rates in Northern Africa, Latin America and Caribbean and Europe. In 
addition, there are large cross-country differences in adult mortality within 
SSA. Premature mortality is a major challenge for SSA. To stem the 
attendant loss of  human capital, preventable  and  manageable  causes  such 
as  HIV/AIDS, malaria  and  tuberculosis  need to be  mitigated  urgently. 
SSA countries are under pressure to increase health expenditure aimed at 
improving adult health.  The average health expenditure per capita in Sub-
Saharan Africa was about US$ 155 in 2011 almost seven times lower than 
the world average (World Bank, 2013). Although efforts to increase public 
health expenditure in SSA such as the Abuja Declaration of 2001 (OAU, 
2001) are yet to be attained (Tandon and Cashin, 2010; World Health 
Organization, 2011), it has increased to close to 10% of government revenue.  
 Although adequate spending on health is important for improving the 
survival and lowering premature adult mortality, more spending may be 
ineffective if institutions and governance structures do not operate properly. 
In particular many SSA countries are characterized by high levels of 
corruption. The average Transparency International Corruption Perception 
Index13 (CPI) for 44 SSA countries was 2.9 out of maximum possible 10 (no 
corruption) Teorell, et al. (2011). Despite the high incidence of corruption in 
SSA, previous studies of the impact of health expenditure on adult health in 
SSA have rarely investigated the role of corruption in the relationship 
between health expenditure and adult health. In addition, the econometric 
methods used in previous studies are subject to bias, which could explain the 
mixed results in the literature. The main purpose of this study is to 
investigate the relationship between health expenditure an adult health in 
                                                          
13 Transparency International (TI) corruption perception index (CPI score relates to 
perceptions  of  the  degree of corruption as  seen by business  people, risk analysts and  the  
general public and  ranges between 10 (highly clean) and 0 (highly corrupt). 
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Sub-Saharan Africa, and the role of corruption levels in that relationship. 
Specifically, estimation of the impact of health expenditure on adult 
mortality in SSA; whether level of corruption affects the impact of health 
spending on adult mortality in SSA; and whether there are regional 
differences in the effect of health care spending and corruption on adult 
mortality in SSA is done.  
 This study extends previous literature in several ways. First, there are 
only a limited number of studies for SSA analysing the relationship between 
health spending and adult health. In particular, the study considers adult 
mortality rate. Adult mortality rate is an indicator of adult health which 
encompasses the maternal mortality and provides a clear picture of probable 
human capital loss between the ages of 15-60 years. Intuitively, these are the 
most active years of individuals and if the society loses them through early 
death the economic consequences can be enormous. Previous studies of adult 
health focused on life expectancy (Aisa, et al., 2014; Yaqub, et al., 2012; 
Novignon, et al., 2012) and maternal mortality rates (Alvarez, et al., 2009). 
However, variability in life expectancy data is low for annual data and most 
studies have had to aggregate data over several years (Filmer and Pritchett, 
1999). Furthermore life expectancy estimates are derivative of age-specific 
mortality rates. The life expectancy also indicate probable number of years 
that individual has to live at birth. Maternal mortality rates are female 
population specific which does not address adult mortality in its entirety. 
Second, few studies in the SSA use dynamic panel models. The study applies 
linear dynamic panel data model (LDPD) (Arellano and Bond, 1991; 
Arellano and Bouver, 1995; Blundell and Bond, 1998) to test the relationship 
between health expenditure, corruption and adult mortality. Linear dynamic 
panel data model controls for endogeneity, stationarity and unobserved 
heterogeneity.  
 Third, existing studies for SSA and other developing regions focused 
mainly on public health spending. In this study, we examine both public and 
private health spending. The level of private health expenditure is relatively 
high in SSA and this study provides evidence on its impact on adult health 
and compares its effectiveness relative to public health expenditure. Fourth, 
only a small number of studies examined the effectiveness of health 
expenditure in SSA. In particular, this study provides an attempt to assess the 
direct impact of corruption on adult health and the influence of corruption on 
the impact of health expenditure on adult health in SSA. Such evidence can 
provide a firm foundation for anti-corruption measures. Finally, the study 
provides evidence on the hypothesis that the effect of health expenditure and 
corruption on adult health may differ according to SSA sub-regions: Western 
Africa, Eastern Africa, Central Africa and Southern Africa. 
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 The remainder of this paper is organized as follows; section 2 
reviews the literature. Section 3 discusses the methodology used in the paper. 
Section 4 presents the results on health expenditure, corruption and adult 
mortality in Sub-Saharan Africa. Section 5 presents a summary, conclusion 
and policy implications.  
 
Literature Review 
Adult Health Outcomes 
 The literature on health expenditure and its relation with adult health 
takes many forms depending on the health outcome and expenditure category 
in question. The World Health Organization (2012) classifies adult health 
outcomes as; adult mortality rates, life expectancy, adult survival rates and 
maternal mortality rates. But WHO also classifies adult health outcomes in 
terms of cause-specific mortality or morbidity.  Although adult mortality 
rates measure the probability of dying within the  age 15-60 years (World 
Health Organization, 2012),  few studies have analysed the effects of health 
expenditure and  other  socio-economic variables on it. Instead most studies 
have considered life expectancy and maternal mortality rates. Life 
expectancy is defined at birth in a reference year, or at a specific age.  
Maternal mortality rate measures the probability of a mother dying per 
100,000 live births. The two health indicators are widely considered policy 
priorities by governments, development partners. For instance, reduction of 
maternal mortality is one of the MDGs (UN, 2000).  
 One can argue that adult mortality is the relevant variable to study the 
consequences of premature mortality in an economy, hence the need for 
health interventions which can reduce it.  Life expectancy may not be 
suitable, Filmer and Pritchett (1999) argued that life expectancy does not 
vary much annually and needs to be aggregated over long periods. Second, 
life expectancy is derived from age-specific mortality rate and in case of data 
inconsistency it can result into wrong interpretation. Third, maternal 
mortality rates capture a  specific segment of  the  population and  is  not  
likely to capture  other  mortality occurring  in the  general population. 
Auster, et al. (1969) argues that adult mortality as a measure of adult health 
is objectively derived, has some accuracy which is reasonable, can be 
accessed readily and is universally accepted. Saikia and Bhat (2008) noted 
that increased adult mortality leads to a fall in labour force which affects 
economic growth, biological reproduction and support to younger and older 
population.  
 
Health Expenditure and Adult Health  
 Empirical literature relating to health expenditure, corruption and 
adult mortality rates is quite rare/little. The studies which have focused on 
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this topic are Auster, et al.  (1969) and Or (2000). Adult health outcomes 
frequently used to measure the effects of health expenditure have included 
life-expectancy and maternal mortality rates. Recent studies focusing on 
health expenditure and life expectancy include; Obrizan and Wehby (2012), 
Yaqub, et al. (2012), Novignon, et al. (2012) and Aisa, et al. (2014). For 
health expenditure and maternal mortality rates, studies are such as Alvarez, 
et al. (2009). 
 
Health Expenditure and Adult Mortality 
 Auster, et al. (1969) studied the link between medical care proxied by 
health expenditure per capita and mortality of white adults using a cross-
section of all US states in 1960. Using OLS the study found that an increase 
in health expenditure by 1% reduced age-adjusted death rates by 0.07%.  
Accounting for endogeneity and simultaneity bias by using 2SLS the results 
indicated that a 1% increase in health expenditure lowered age-adjusted 
death rates by 0.12%.  Further classification  of  the  age-adjusted  deaths  by 
categories such as white collar workers, female  not  in labour  force 
indicated that an increase in health expenditure by 1% reduced  it by 0.1%  
and  0.9%  respectively in the two groups. The study concluded that medical 
service had a relative importance in reduction of adult mortality in US.  Or 
(2000) examined the determinants of premature mortality using a panel of 21 
OECD countries for the period 1970 to 1992. Premature mortality for both 
women and men was defined by potential years of life lost. Fixed effect 
model results showed that increasing total health expenditure per capita by 
1% reduced premature mortality in women by 0.18%. Additionally, the study 
found that raising public health expenditure as a percent of total health 
expenditure lowered premature mortality in men by 0.18% and women by 
0.16%. The paper concluded that increasing health expenditure is crucial in 
the reduction of premature mortality especially those of women. The  study 
does  not account  for  endogeneity of  health expenditure  in the  premature  
mortality equations for  men and  women. 
 
Health Expenditure and Other Adult Health Outcomes 
 Aìsa, et al (2014) studied the influence of public health expenditure 
on longevity using a panel of 29 OECD countries from 1960-2000 (5 yearly 
averaged data) using fixed effect model. The fixed effects estimates showed 
that an increase in public health expenditure by 1% increased life expectancy 
by about 0.13%. The nonlinear fixed effect estimates, showed that increasing 
public health expenditure by 1% increased life expectancy by 0.21%. The 
study also examined effect of public and private health expenditure on life 
expectancy. Raising public health expenditure and its ratio to private health 
expenditure by 1% increased life expectancy by 0.11% respectively though 
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weakly. The study does not account for endogeneity for total, public and 
private health expenditure in the longevity equation. This may explain the 
weak relationships throughout the estimations. Novignon, et al. (2012) 
examined the relationship between total, public and private health 
expenditure and, life expectancy in Sub-Saharan Africa  using  a  panel of  
44 countries for  the  period  1995 to 2010.  The fixed effects estimates 
showed that increasing total public and private health expenditure by 1% 
increased life expectancy in SSA by 0.44 years. This study does not account 
for endogeneity of the health expenditure measures with regard to the life 
expectancy equations. Craigwell, et al. (2012) investigated the effects of 
public health expenditure on life expectancy for a panel of 19 Caribbean 
countries in the period 1995-2007. Using panel OLS, the estimates indicated 
that an increase in government health expenditure by 1% raised life 
expectancy by 0.03%.  Like Novignon, et al. (2012) the paper did not 
account for endogeneity of public health expenditure in the life expectancy 
model.  
 Obrizan and Wehby (2012) examined the link between health 
expenditure per capita and life expectancy for males and females using OLS 
and quantile regression approach for 177 countries. The data used ranged 
from 2006-2008 for life expectancy, 1997-1999 for health expenditure and 
control variables 2005-2007. The authors argued that they used 1997-1999 
data for health expenditure to reduce simultaneity bias by lagging it for 10 
years. This is   due  to variations in productivity and  increased  health care  
spending  in some  countries, thus  allowing  time  for  realisation of  the  
health expenditure effects. The results showed that health expenditure had 
positive and significant effects across the life expectancy quantiles. 
Increasing health expenditure per capita by US$ 100 raised life expectancy 
of males by 4.13 to 11.5 months while that of the females increase by 5.3 
months to 11.9 months. The paper does not account for endogeneity of health 
expenditure per capita in the life expectancy models. It also cautions that not 
accounting for unobserved heterogeneity among the countries studied might 
have led to lower coefficient estimates.  
 Yaqub, et al. (2012) examined the influence of public health 
expenditure and governance on life expectancy in Nigeria for the period 
1980-2008 using OLS and 2SLS. OLS estimates indicated that increasing 
public health expenditure by 1% reduced life expectancy by 0.004% but  
when the  interactive  term for  public  health expenditure and  corruption 
index  it became  positive ( 0.02%). A 1% decrease in corruption index 
increased life expectancy by 0.02%.  The interaction between corruption 
index and public health expenditure was negative. Controlling for 
endogeneity through 2SLS, the estimates showed that public health 
expenditure reduced life expectancy by 0.02%. Just like OLS, after 
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controlling for corruption the interactive term was positive. The weakness of 
this study arises from small sample and it did not take into account the time 
series properties of the data. Alvarez, et al. (2009) studied factors influencing 
maternal mortality in Sub-Saharan Africa for the period between 1997 and 
2006. The paper used correlation analysis and found that per capita 
government health expenditure explained reduction of maternal mortality by 
45%. The weaknesses   of the paper arises from the fact that correlation does 
not measure causality between health expenditure and maternal mortality 
rate.  
 In summary, there is limited literature available on the relationship 
between health expenditure, corruption and adult mortality. Most of the 
studies focused on the link between health expenditure and life expectancy 
or health expenditure and maternal mortality. This study focuses on adult 
mortality rates. Some studies used OLS and ignored potential endogeneity of 
health expenditure. Others used 2SLS to control for endogeneity of health 
expenditure, but ignore unobserved heterogeneity across countries. A few 
used static panel models (fixed effects and random effects). However, static 
panel models do not account for endogeneity of health expenditure and 
dynamics. Consequently, there are conflicting results and methodological 
problems that should be addressed. This study incorporates a governance 
variable and used the linear dynamic panel model (GMM-Instrumental 
Variable) to examine the impact of health expenditure and level of 
corruption and their interaction on adult mortality. The GMM-IV estimator 
uses lag-differences and level of variables as instruments to account for 
endogeneity of health expenditure in the adult mortality equations. This 
provides robust estimates. 
 
Methodology 
Conceptual Model of Health Expenditure, Corruption and Adult Health 
A country benefits more from healthy adults through improved human 
capital. Subsequently, human capital improvement leads to high labour 
productivity, investment, consumption and economic growth. Therefore 
investment in activities that can improve adult health through reduction of 
mortality is important for a country’s economic development. The 
interventions which can reduce adult mortality include adequate health 
expenditure on health programmes that target adults,  increased  income  per  
capita, reduced  HIV infections and  management  of  AIDS related  illnesses 
and improved  adult literacy. The conceptual model is shown 
diagrammatically in Figure 1. 
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Figure 1: Conceptual Model for Health Expenditure, Corruption and Adult Mortality 
 
 
Increasing health expenditure targeting adult health interventions, 
allows accessibility to health care which reduces adult mortality from 
communicable and noncommunicable diseases.  Communicable diseases 
which affect adults are likely to be HIV/AIDS, lower respiratory infections 
and maternal related infections while non communicable disease are likely to 
be diabetes, hypertension, cancer and  cardiovascular  diseases (Lopez, et al., 
2006). Improving transparency and accountability (lowering corruption 
levels) in resource use, is imperative to reduce adult mortality. This is 
because  quality health care services are  likely to be  realized  when health 
workers  productivity is  high, availability of drugs, reduced  in-kind  
payments  and  no diversion of  funds  from the system (Lewis, 2006).  The 
role of corruption in enhancing effectiveness of health expenditure cannot be 
ignored as it imperative for better adult health outcomes such as reduced 
mortality. Regional differences may also have an influence on effectiveness 
of health expenditure in reduction of adult mortality. This is  because  they 
have varied  health  policies  and  priorities that are  likely to influence  adult  
health in  different  ways. The regions in the conceptual model are Eastern 
Africa, Western Africa, Southern Africa and Central Africa. 
 Increased income can improve quality of living through access to 
good nutrition, housing and working conditions, access to quality health care 
and education which are likely to prolong life in adults. HIV/AIDS has been 
one of the fundamental health problem which has increased adult mortality 
since its discovery in early 1980s. Therefore, reducing new HIV infections 
and management of AIDS through access to anti-retroviral therapy (ART) is 
likely to lower adult mortality. Improved adult literacy leads to effective 
consumption of health information and may increase time preference for 
adults (Becker and Murphy, 1988). This is likely to lead adults to make 
lifestyle choices which are likely to improve their health such as good 
nutrition, and avoidance of risky behaviours (unprotected sex, smoking, and 
overindulgence on alcohol). 
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Theoretical Model 
 The theoretical model that guides the empirical methodology is based 
on Rajkumar and Swaroop (2008) and Yaqub, et al. (2012) health production 
model. The link between health expenditure, corruption and adult mortality 
is shown in the following health production function. 
𝑀 = 𝑓 ( 𝑅𝐺𝐷𝑃𝐶,𝐻𝐸𝑋𝑃,𝐶𝑂𝑅)……………………………………………....(4.1) 
𝑀 is adult mortality rate. 𝑅𝐺𝐷𝑃𝐶 is real GDP per capita (real income per 
capita), 𝐶𝑂𝑅 is level of corruption. From Equation 4.1 the model assumes 
that; increase in real income per capita leads to a reduction in adult mortality. 
This is through, allocation of resources to interventions in the health sector 
that focus on adult health and improved welfare of individual in terms of 
access to good nutrition, living condition and quality health care.  Health 
expenditure affect adult health through provision of health interventions such 
as contraceptives, ante-natal care and skilled child delivery services, anti-
retroviral therapy, screening and prevention of non-communicable diseases. 
Access to this health services may improve quality of life through lowering 
both morbidity and mortality among adults. Lowering corruption in the 
health sector may result in resource efficiency which is likely to result in 
effective use of health resources, hence better adult health. 
 Model (4.1) is transformed in a Cobb-Douglas health production 
model (4.2). The relationship between health expenditure, real income per 
capita, corruption and adult mortality (adult health) is expressed as follows. 
𝑀𝑖𝑡 = 𝐴(𝑅𝐺𝐷𝑃𝐶𝑖𝑡)𝜉 ∗ (𝐻𝐸𝑋𝑃𝑖𝑡)𝜓 ∗(𝐶𝑂𝑅𝑖𝑡)𝜆……………………………………………................................(4.2) 
 In this study 𝑀𝑖𝑡 is defined as adult mortality rates. 𝑅𝐺𝐷𝑃𝐶𝑖𝑡 is real 
income per capita; and 𝐻𝐸𝑋𝑃𝑖𝑡 represents health spending (total, public 
and/or private health care spending). 𝐶𝑂𝑅𝑖𝑡 is level of corruption. 𝐴 
measures changes in technology which is assumed to be constant. Taking the 
logarithms of equation (4.2) transforms into linear equation which is written 
as follows. 
𝑙𝑛 𝑀𝑖𝑡 = 𝑙𝑛𝐴 + 𝜉𝑙𝑛 𝑅𝐺𝐷𝑃𝐶𝑖𝑡 + 𝜓𝑙𝑛 𝐻𝐸𝑋𝑃𝑖𝑡 +
𝜆𝑙𝑛 𝐶𝑂𝑅𝑖𝑡    ……………………………....................................................(4.3) 
 The parameters can be defined as follows: 𝜉 is the coefficient of real 
income per capita measuring the elasticity of adult mortality with respect to 
change in real income per capita. 𝜓 is the coefficient of health spending 
measuring the elasticity of adult mortality with respect to change in health 
expenditure. 𝜆 is the coefficient of corruption measuring the change in adult 
mortality with respect to change in governance (through reduced corruption).  
 Assuming that some part of health spending (total, public and 
private) is lost or wasted due to corruption, this has consequences on the 
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effectiveness of health spending. Following Yaqub, et al. (2012) and 
Pritchett (1996), let  𝜛(. )  denote the part of resources allocated to health 
that is spent on productive purposes. The 𝜙 coefficient of health spending 
on, say programme 𝑝 takes the form; 
𝜙 = 𝛿(. ) ∗
𝜙𝑝…………………………….…………………..………………………(4.4) 
 Where 𝜙𝑝 represents the productivity of public or private capital that 
is created from spending on health programme  𝑝. Assume that 𝛿(. ) 
measures the effectiveness of health spending it can be expressed as a 
function of state corruption 𝐶𝑂𝑅𝑖𝑡. Then,   
𝛿 = 𝜛0 +
𝜛1𝐶𝑖𝑡……………………………………………………………......…....(4.5) 
 Substituting equations (4.4) and (4.5) into (4.3) results into the 
following equation; 
𝑙𝑛 𝑀𝑖𝑡 = 𝑙𝑛𝐴 + 𝜉𝑙𝑛 𝑅𝐺𝐷𝑃𝐶𝑖𝑡   + 𝜙𝑝(𝜛0 + 𝜛1𝐶𝑂𝑅𝑖𝑡)𝑙𝑛 𝐻𝐸𝑋𝑃𝑖𝑡 ∗+𝜆𝑙𝑛 𝐶𝑂𝑅𝑖𝑡  ………..................................................................................(4.6) 
 
Empirical Models 
 To estimate the impact of health expenditure and corruption on adult 
mortality rate as well as how level of corruption has influenced effectiveness 
of health expenditure three models are specified. The baseline model 
measures the effect of health expenditure on adult mortality and is specified 
with control variables. The model is written as follows.   
𝑙𝑛𝑀𝑖𝑡 = 𝜚0 + 𝜚1𝑙𝑛𝐻𝐸𝑋𝑃𝑖𝑡 + 𝑋𝑖𝑡′ 𝛤 +
𝜀𝑖𝑡…………………………………………………......................................4.7 
 To estimate the impact of corruption on adult mortality rates, model 
(4.7) is extended by adding the corruption index. 
𝑙𝑛𝑀𝑖𝑡 = 𝜁0 + 𝜁1𝑙𝑛𝐻𝐸𝑋𝑃𝑖𝑡 + 𝜁2𝑙𝑛𝐶𝑂𝑅𝑖𝑡 + 𝑋𝑖𝑡′ 𝛤 +
𝑣𝑖𝑡………………………………..................................................................4.8 
 Interaction of corruption index and health expenditure is added to 
model (4.8) to measure how corruption influences effectiveness of health 
expenditure on adult mortality rates. 
𝑙𝑛𝑀𝑖𝑡 = 𝜂0 + 𝜂1𝑙𝑛𝐻𝐸𝑋𝑃𝑖𝑡 + 𝜂2𝑙𝑛𝐶𝑂𝑅𝑖𝑡 + 𝜂3[𝐶𝑂𝑅𝑖𝑡 ∗ 𝑙𝑛𝐻𝐸𝑋𝑃𝑖𝑡] + 𝑋𝑖𝑡′ 𝛤 +
𝜇𝑖𝑡……..........................................................................................................4.9 
 Equations (4.7), (4.8) and (4.9) relate natural log of adult mortality 
rates to natural log of health expenditure, natural log of corruption index and 
interaction of corruption index and natural log of health expenditure. 
𝑙𝑛 𝑀𝑖𝑡  is the natural log of adult mortality rates; 𝐻𝐸𝑋𝑃𝑖𝑡 is natural log of  
health expenditure (total, public and/or private); 𝐶𝑂𝑅𝑖𝑡 is the natural log of 
corruption index;  𝐶𝑂𝑅𝑖𝑡 ∗ 𝑙𝑛𝐻𝐸𝑋𝑃𝑖𝑡 is the interaction of corruption index 
and the natural log of health expenditure. The interaction term is used to 
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determine how level of corruption affects the impact of health expenditure 
on adult mortality. 𝑋𝑖𝑡 is a vector of control variables. The control variables 
are natural log of real income per capita, natural log of adult literacy rates, 
HIV prevalence rates and natural log of ethnic fragmentation. Where 𝜀𝑖𝑡, 𝑣𝑖𝑡 
and 𝜇𝑖𝑡  are composite error terms. They consists of individual-specific 
effects and time-specific effects. The composite error terms are assumed to 
be normally distributed and homoscedastic. 𝜚1, 𝜁1 𝑎𝑛𝑑 𝜂1 are the coefficients 
of health expenditure and are expected to be negative. 𝜁2 𝑎𝑛𝑑 𝜂2 are the 
coefficients of the corruption and are expected to be negative. 𝜂3 is the 
coefficient of the interaction of corruption index and health expenditure and  
the signs can be either positive and negative. 𝛤-is the vector of coefficients 
of the control variables. 
 The regional differences in the impact of health expenditure and 
corruption on adult mortality rates is estimated through three models. The 
three models are characterised by adding regional dummy variables and 
interacting them with health expenditure and corruption.  
 The first model for regional differences on effect of health 
expenditure on adult mortality rates is written as follows.  
𝑙𝑛𝑀𝑖𝑡 = 𝜚0 + 𝜚1𝑙𝑛𝐻𝐸𝑋𝑃𝑖𝑡 + 𝜚2𝐸𝐴𝑖 + 𝜚3𝐶𝐴𝑖 + 𝜚4𝑊𝐴𝑖 + 𝜚5[𝐸𝐴𝑖 ∗
𝑙𝑛𝐻𝐸𝑋𝑃𝑖𝑡] + 𝜚6[𝐶𝐴𝑖 ∗ 𝑙𝑛𝐻𝐸𝑋𝑃𝑖𝑡] + 𝜚7[𝑊𝐴𝑖 ∗ 𝑙𝑛𝐻𝐸𝑋𝑃𝑖𝑡] +
𝑋𝑖𝑡
′ 𝛤 + 𝜔𝑖𝑡………………………………. ..............................(4.10) 
 The second model is an extension of model (4.10) capturing the 
regional differences on effect of corruption on adult mortality rate. 
𝑙𝑛𝑀𝑖𝑡 = 𝜁0 + 𝜁1𝑙𝑛𝐻𝐸𝑋𝑃𝑖𝑡 + 𝜁2𝐸𝐴𝑖 + 𝜁3𝐶𝐴𝑖 + 𝜁4𝑊𝐴𝑖 + 𝜁5[𝐸𝐴𝑖 ∗
𝑙𝑛𝐻𝐸𝑋𝑃𝑖𝑡] + 𝜁6[𝐶𝐴𝑖 ∗ 𝑙𝑛𝐻𝐸𝑋𝑖𝑡] + 𝜁7[𝑊𝐴𝑖 ∗ 𝑙𝑛𝐻𝐸𝑋𝑖𝑡] +
𝜁8𝑙𝑛𝐶𝑂𝑅𝑖𝑡 + 𝜁9[𝐸𝐴𝑖 ∗ 𝑙𝑛𝐶𝑂𝑅𝑖𝑡] + 𝜁10[𝐶𝐴𝑖 ∗ 𝑙𝑛𝐶𝑂𝑅𝑖𝑡] +
𝜁11[𝑊𝐴𝑖 ∗ 𝑙𝑛𝐶𝑂𝑅𝑖𝑡] +
𝑋𝑖𝑡
′ 𝛤+𝜅𝑖𝑡………………............................... ..........................(4.11) 
 The third model extends model (4.11) by adding the interaction of 
corruption and health expenditure at the regional level. It measures how 
corruption influences health expenditure effectiveness on adult mortality 
rates in SSA sub regions. 
𝑙𝑛𝑀𝑖𝑡 = 𝜂0 + 𝜂1𝑙𝑛𝐻𝐸𝑋𝑃𝑖𝑡 + 𝜂2𝐸𝐴𝑖 + 𝜂3𝐶𝐴𝑖 + 𝜂4𝑊𝐴𝑖 + 𝜂5[𝐸𝐴𝑖 ∗
𝑙𝑛𝐻𝐸𝑋𝑃𝑖𝑡] + 𝜂6[𝐶𝐴𝑖 ∗ 𝑙𝑛𝐻𝐸𝑋𝑃𝑖𝑡] + 𝜂7[𝑊𝐴𝑖 ∗ 𝑙𝑛𝐻𝐸𝑋𝑃𝑖𝑡] +
𝜂8𝑙𝑛𝐶𝑂𝑅𝑖𝑡 + 𝜂9[𝐸𝐴𝑖 ∗ 𝐶𝑂𝑅𝑖𝑡 ∗ 𝑙𝑛𝐻𝐸𝑋𝑃𝑖𝑡] + 𝜂10[𝐶𝐴𝑖 ∗ 𝐶𝑂𝑅𝑖𝑡 ∗
𝑙𝑛𝐻𝐸𝑋𝑃𝑖𝑡] + 𝜂11[𝑊𝐴𝑖 ∗ 𝐶𝑂𝑅𝑖𝑡 ∗ 𝑙𝑛𝐻𝐸𝑋𝑃𝑖𝑡] + 𝑋𝑖𝑡′ 𝛤 + 𝜆𝑖𝑡 .. (4.12) 
 Equations (4.10), (4.11) and (4.12) relates natural log of adult 
mortality with natural log of health expenditure, regional dummy variables 
Eastern Africa (EA), Central Africa (CA) and Western Africa (WA), 
interaction of regional dummy variables with natural log of health 
expenditure, natural log of corruption index, interaction of regional dummy 
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variables with natural log of corruption index, interaction of regional dummy 
variables with corruption index and natural log of health expenditure. The 
control variables are as defined in earlier equations. Where 𝜔𝑖𝑡, 𝜅𝑖𝑡 and 𝜆𝑖𝑡  
are composite error terms.  
 
Estimation 
 The econometric models specified in section 3.3 were estimated 
using panel static panel and dynamic panel data models. The static panel data 
methods used in the study are fixed effect (FE) and random effect (RE) 
models. The weakness of the models is that they are based on country 
specific effects and they do not account for stationarity and endogeneity. 
Health expenditure could be endogenous in mortality equations if there are 
omitted variables and reverse causality. For instance, economic shocks, 
population changes and political shocks are likely to be omitted variables 
correlated with health expenditure. Reverse causality may arise when 
increase in adult mortality triggers SSA governments and households to 
increase health expenditure. On the other hand, increase in health 
expenditure may lead to lower adult mortality rates. There are also problems 
of unobserved heterogeneity and lagged dependent variable in dynamic 
models. Estimation under these problems can produce inconsistent and 
biased estimates. To account for these weaknesses linear dynamic panel 
model  (Arellano and Bond, 1991; Arellano and  Bover, 1995;  Blundell and  
Bond, 1998) which is based on the  principles  of GMM-IV was  used  as  the  
key estimation technique.  The  merits of  linear  dynamic  panel is  the 
assumption of  strict exogeneity and stationarity restrictions  and  its  ability 
to derive  robust results  when dynamic  instruments  are  used. The 
instruments are specified at lag differences, differences and levels. Table 2 




 This section presents the descriptive statistics for all variables used in 
the study. From Table 3, the mean adult mortality rate was 364.8 per 1000 
adults across 41 SSA countries. The countries with the highest adult 
mortality within the period had 616 per 1000 adults, compared with the 
lowest of 116.9 per 1000 adults. These disparities provides an uneven 
challenge in joint policies in the SSA to reduce premature mortality. The 
average public health spending was about US$ 759 Million (2000, constant) 
while the average private health care spending was 1.4 times higher than the 
public expenditure. Total health spending averaged at US$ 1,890 million. 
The total health spending had a ratio of public and private health expenditure 
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at 1:1.5. This indicates that the burden of health expenditure is leaning more 
towards the households rather than the government.  
 The mean Corruption Perception Index of 3.02 out of a possible 10, 
shows that corruption levels are perceived to be high in SSA. This is likely to 
affect resource allocation and its effectiveness in various sectors including 
the health sector. Thus, health expenditure may be ineffective on reducing 
adult mortality when corruption levels are high. The variability in real GDP 
per capita in SSA is quite high as the standard deviation shows. The average 
HIV prevalence rate was about 6.2% but in one country it was 26.3%.  
Average adult literacy measured as primary school gross enrolment ratio was 
96.6.  However, one of the country had very low literacy rates of 32.2 for 
adults.  The average ethnic fragmentation (a proxy for social cohesion) was 
0.63. This indicates the ethnic diversity in SSA which might result in 
frequent social and political conflicts in public resource allocation thus 
affecting health care. 
 
Econometric Estimates for Health Care Spending, Corruption and 
Adult Mortality in SSA 
 The econometric estimates are shown in Table 4. A baseline model 
relating public and private health expenditure to adult mortality rates is 
shown in Model 1. Model 2 augments model 1 by adding corruption index to 
determine its effects on adult mortality rates. Model 3 extends model  2 by 
including the interaction terms (public health expenditure and  corruption 
index,  and  private health and corruption index) to measure  the influence of  
levels  of corruption on effect of  public  and  private  health expenditure on 
adult mortality.  Arellano-Bond test for autocorrelation cannot reject the null 
of no serial correlation as its p-value is larger than 0.10. The p-value of Wald 
test is zero, indicating that the null hypothesis of joint significance of the 
coefficient estimates can be rejected. Sargan test fails to reject the null of 
over identification restriction being valid because the p-value is large. Thus, 
the instruments used are valid.  
 In model 1 (the baseline model) the coefficient estimate of public 
health expenditure is positive while that of private health expenditure is 
negative. Both of them are significantly related to adult mortality. A rise in 
public health expenditure by 1% increases adult mortality by 0.05%, but 
increasing private health expenditure lowers adult mortality by 0.08%. From 
the results, private health expenditure is relatively more effective in 
reduction of adult mortality than public health expenditure.  When perceived 
level of corruption is factored in model 2 the public health expenditure 
coefficient is positive but insignificant. This result is in contrast to that of Or 
(2000). Or (2000) found that increasing public health expenditure reduced 
premature mortality in men and women respectively. Novignon, et al. (2012) 
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found that public health expenditure increased life expectancy in SSA. The 
coefficient of private health spending has a negative and significant link with 
adult mortality. Thus, indicating that an increase in private health spending 
by 1% decreased adult mortality rates by about 0.11%. A study by 
Novignon, et al. (2012) showed that an increase in private health expenditure 
raised life expectancy. Thus when corruption is controlled, private health 
expenditure crowds out the effect of public health expenditure on adult 
mortality. The corruption coefficient is negative and significant. Thus, 
reducing levels of corruption by 1% decreases adult mortality rates by about 
0.18%. Yaqub, et al. (2012) showed that when corruption levels are reduced, 
life expectancy in Nigeria increased. The other explanatory variables are 
significant and have right signs. 
 When the interactions of public and private health expenditure with 
corruption index are added in model 3, the estimate of public health 
expenditure is negative while that of a private health expenditure is positive 
and significantly related to adult mortality. The coefficients of interactive 
variables (public health expenditure and corruption index (positive) and, 
private health expenditure and corruption index (negative)) are significant. In 
Yaqub, et al. (2012) the interaction terms between public health expenditure 
and corruption index was negative. The results obtained in model 3 are used 
to derive the effectiveness of both public and private health expenditure on 
adult mortality with respect to changes in corruption levels in Table 5. When 
the  corruption levels  are high  (for instance, CPI=1) , an  increase in public  
health spending by 1%  lowers  adult  mortality  by about 0.23%.  On the 
other hand, a rise in private health spending by 1% leads to an increase in 
adult mortality by about 0.19%. In situations of low perceived corruption 
(for instance, CPI=6.4), raising public health spending by 1% increases adult 
mortality by about 0.12%. On the other hand, increasing private health 
spending by 1% leads to a fall in adult mortality by about 0.14%. 
 The above  results  for  the  effectiveness  of  both  public  and  
private  health expenditure exhibit a substitutability given the corruption 
levels. One can observe that  when there  is  high  corruption public  health 
expenditure  is  more  effective  than the  private  health expenditure. This 
may occur when citizens are willing to participate in corruption to obtain 
certain health services (Gupta, et al., 2000). Furthermore, corruption 
situations like staff absenteeism, in-kind payments and pilferage of drugs 
might be left unattended to for so long. Hence  when such  corruption is 
controlled  in the  public  health sector  they transfer  their  services to the  
private health sector  by referring  their  patients to private  clinics. This may 
explain the high effectiveness of private health expenditure when there is 
low perceived corruption.  
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Regional Differences of Health Care Spending in Reducing Adult 
Mortality Rates in Sub-Saharan Africa 
 This section discusses the regional variations in effectiveness of 
public and private health expenditure and corruption on adult mortality 
reduction in Tables 6 and 7. The variations are discussed using three models. 
Model 4 is characterised by examining the relation between the regional 
public and private health expenditure (interaction of regional dummy 
variable with public and private health expenditure respectively) and adult 
mortality. Model 5 is extended by adding the regional corruption levels 
(interaction of corruption index and regional dummy variables).  Model 6 
augments the two previous models by including the interaction of the 
regional public and private health expenditure with corruption index. This is 
to determine the effectiveness of both public and private health expenditure 
with respect to corruption levels on lowering adult mortality. Wald test p-
value (0.00) indicates that the null hypothesis of no joint significance is 
rejected in the three GMM models. Arellano-Bond estimates are all 
insignificant indicating that the first differenced error in the models are not 
serially correlated. Sargan test estimates are insignificant indicating that the 
null hypothesis of over identifying restrictions being valid cannot be 
rejected. Therefore the instruments specified in all three models are valid. 
 The  key variables for  public  health expenditure, private  health 
expenditure and level of  corruption  used  in deriving  the  regional 
variations  are  all significant and  have  mixed  signs. The estimates of 
public and private health expenditure and corruption levels are used in Table 
7 to compute their regional differences. In the baseline regional model 
(Model 4a) on effectiveness of public and private health expenditure on adult 
mortality rate, increasing public health expenditure results in lower adult 
mortality. But public health expenditure is more effective in Western Africa 
than the other three regions. For instance, in Western Africa a 1% increase in 
public health expenditure reduces adult mortality by 0.36%. This is followed 
by Southern Africa at 0.19%.  Turning to private health expenditure, 
increasing private health expenditure worsen adult mortality rate in all the 
regions. Therefore, public health expenditure substitutes private health 
expenditure in all the regions in reducing adult mortality rates.  Adding the 
corruption perception index in Model 5a, Southern Africa public health 
expenditure becomes more effective than the other three regions. On the 
other hand, in Central Africa the coefficient of public health expenditure 
becomes positive and its private health expenditure coefficient becomes 
negative. Central Africa has a more effective private health expenditure than 
the other three regions. All other three regions (Eastern, Southern and 
Western Africa) have positive private health expenditure indicating that it’s 
worsening adult mortality rates. 
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 The regional differences in effectiveness of public and private health 
expenditure with respect to average corruption levels is shown in model 6a. 
When faced with average corruption levels (e.g. CPI = 3) public health 
expenditure in Southern Africa and Central Africa increases adult mortality. 
However it is different with private health expenditure as it is more effective 
in reducing adult mortality in the two regions. Raising private health 
expenditure by 1% in the two regions lowers adult mortality by 0.16% and 
0.43% respectively. All the four regions substitute either public health 
expenditure or private health expenditure in reducing adult mortality rates.  
The results in model 6a show that when control of corruption takes effect 
there are regions that substitute public health expenditure with private health 
expenditure. This is because if the corrupt health workers or administration 
are no longer benefitting from the public health system they may move 
resources to private health systems to provide better services or the other 
way round. For example, a physician working in the public health facility 




 This study examined the link between health expenditure and adult 
health in Sub-Saharan Africa and how level of corruption influences that 
relationship. Despite the intergovernmental and development partner’s 
efforts to improve adult health, adult mortality rates in SSA are still higher 
than the rest of the world. More interventions are needed to reduce premature 
mortality among the economically active population in SSA. Increasing 
public health expenditure under the Abuja declaration commitment has been 
one of the policy directive from the AU heads of states, but it is yet to be 
fully implemented (Tandon and Cashin, 2010). While increasing health 
spending will provide more resources to health sectors in SSA this may have 
little effect on health outcomes if the institutional environment is distorted. 
There is evidence that levels of corruption in SSA are high. This study 
significance arises from the dearth of literature on the link between health 
expenditure, corruption and adult mortality rates. Most studies concerned 
with adult health have studied indicators such as life expectancy and 
maternal mortality rates and linked them with health expenditure in SSA. 
This paper also provides new evidence of effectiveness of health expenditure 
given corruption. Yaqub, et al. (2012) work in Nigeria, is the first study 
measuring effectiveness of health expenditure in Sub-Saharan Africa. This 
paper applies  General Methods  of  Moments  IV  linear dynamic  panel data  
model (LDPD)   developed  by Arellano and Bond  (1991), Arellano and 
Bover (1995), and  Blundell and Bond  (1998).   
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 The results of the study indicate that private health expenditure is 
more effective in reduction of adult mortality more than public health 
expenditure. As  private  health expenditure  is  increased  it reduces adult  
mortality while  raising  public  health expenditure  makes  it worse  or it is 
crowded out in Sub-Saharan Africa. Therefore, private health expenditure 
substitutes public health expenditure. This shows that most adults in the SSA 
are highly vulnerable in case of high out-of-pocket payments. Reducing 
corruption levels leads to a fall in adult mortality rates. Curbing corruption 
levels is likely to influence the effectiveness of health expenditure in 
reducing adult mortality rates.  For instance, when corruption levels are low 
total health expenditure is more effective in reduction of adult mortality than 
when there are high corruption levels. When corruption levels  are  low, 
private  health expenditure  is  more  effective  in  reducing  adult  mortality 
than public  health expenditure.  
 In regional variations, public and private health expenditure in all 
regions have shown that public health expenditure is more effective than 
private counterpart. In the baseline and the second model (after controlling 
for corruption), Western and Southern Africa have the highest effectiveness 
of public health expenditure in reducing adult mortality. Central Africa 
private health expenditure is more effective in reducing adult mortality than 
its public health expenditure. Reducing corruption levels in Western and 
Central Africa is more effective in lowering adult mortality than in Southern 
and Eastern Africa. When public and private health are moderated by 
corruption levels (at the average CPI = 3 in SSA), Western Africa public 
health expenditure is more effective in lowering adult mortality than Eastern, 
Central and Southern Africa. On the other hand, private health expenditure in 
Southern Africa, Eastern Africa and Central Africa is more effective than 
Western Africa. This shows that public and private health expenditure are 
substitutes in all the regions when corruption influences their effectiveness 
on adult mortality. Increased real income per capita and ability of adult to 
read and write influenced reduced adult mortality. On the other hand, 
increased HIV prevalence rates (proxy for new HIV infections)   and ethnic 
fragmentation (low social cohesion) raised adult mortality.  
 In conclusion, the  finding  of  the  study have  confirmed  that  
adequate health expenditure plays  a significant role  in reduction of  
premature  mortality in SSA. The  issue  of strong  effectiveness  of  private  
health expenditure on adult mortality bring  a  problem of  vulnerability of  
households to catastrophic  health expenditure.  Policy makers can alleviate 
this problem by introducing social protection measures such as voluntary or 
universal health insurance. This can effectively cover their medical care and 
also help mitigate against impoverishing risks of high out-of-pocket 
spending. SSA countries can also renew their efforts in enforcing the Abuja 
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Declaration by allocating more funds to public health sector focusing on 
adult health care. Transparency and accountability can enhance efficiency of 
resources allocated to health care.  SSA governments can improve adult 
health by integrating the health system by ensuring homogeneity in health 
expenditure and reducing corruption incidences in their respective countries. 
Improving transparency and accountability which is likely to reduce 
corruption is relevant for making systems to work properly and improve 
health service delivery. Thus as result of improved health service delivery 
lower adult mortality can be realised in SSA. Regional differences in the 
effects and effectiveness in health expenditure provides a challenge in 
integrating health systems in the SSA. 
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Table 1: Regional Comparison of Adult Mortality Rates across the World 
 Deaths Under-Age  of 60 per 1000 alive at age 15 
Region 1995-2000 2000-2005 2005-2010 
Sub-Saharan Africa 401 410 383 
Northern Africa 187 160 143 
South-Central Asia 239 224 210 
South-Eastern Asia 214 198 184 
Latin America and 
Caribbean 
171 160 148 
Europe 164 163 148 
North America 116 110 108 
Oceania 128 115 107 
Source of data: UN DESA (2011). 
 
Table 2: Data Sources and Definition of Variables 
Variable 
Name 




Adult mortality rate is the probability of dying 
between the ages of 15 and 60 that is  the probability 
of a 15-year-old dying before reaching age 60, if 
subject to current age-specific mortality rates 







Public health expenditure consists of recurrent and 
capital spending from government (central and local) 
budgets, external borrowings and grants (including 
donations from international agencies and 
nongovernmental organizations), and social (or 
compulsory) health insurance funds. Measured as the 









Private health expenditure includes direct household 
(out-of-pocket) spending, private insurance, 
charitable donations, and direct service payments by 










GDP per capita based on purchasing power parity 
(PPP). PPP GDP is gross domestic product converted 
to international dollars using purchasing power parity 





HIV Prevalence of HIV refers to the percentage of people World  









Reflects probability that two randomly selected 
people from a given country will not belong to the 
same ethnolinguistic group. The higher the number, 
the more fractionalized society. The definition of 
ethnicity involves a combination of racial and 












The CPI focuses on corruption in the public sector 
and defines corruption as the abuse of public office 
for private gain. The surveys used in compiling the 
CPI tend to ask questions in line with the misuse of 
public power for private benefit, with a focus, for 
example, on bribe-taking by public officials in public 
procurement. The sources do not distinguish between 
administrative and political corruption. The CPI 
Score relates to perceptions of the degree of 
corruption as seen by business people, risk analysts 
and the general public and ranges between 10 (highly 








Total gross enrolment ratio is the ratio of total 
enrolment, regardless of age, to the population of the 
age group that officially corresponds to the level of 
education shown. This is a basic measure for literacy 







Table 3: Descriptive Statistics of Variables Included in the Adult Mortality Equation 
Variable Obs Mean Std. 
Dev 
Min Max 
Adult Mortality Rates    (AMR)  per 1000 
adults) 
402 364.8 108.5 116.9 616.3 
Public Health Expenditure (Million US$ 
Constant 2000) 
410 759 2,160 4.98 15,700 
Private Health Expenditure  (Million Constant  
2000 US$) 
410 1,130 3,490 7.4 23,500 
Real GDP per Capita (2005, PPP 
International US$) 
409 3259.4 4998.2 346.1 31738.2 
HIV Prevalence Rate (%) 370 6.2 7.1 0.1 26.3 
Ethnic Fragmentation 410 0.63 0.23 0.01 0.93 
Transparency International-Corruption 
Perception Index (TICPI) 
276 3.02 1.06 1 6.4 
Adult  Literacy 410 96.6 25.2 32.2 154.2 
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Table 4: Effects of Public and Private Health Expenditure, Corruption on Adult Mortality 
Rates (Dependent Variable is ln (Adult Mortality Rates)) 
Independent 
Variables 
Model 1 Model 2 Model 3 
FE RE LDPD FE RE LDPD FE RE LDPD 










































ln (Real Gross 






























































































































Number  of 
Observations 





- - 65.82 
(0.00) 
- - 51.41 
(0.00) 
- - 
R-Squared 50.49 49.51 - 64.86 64.39 - 65.98 65.58 - 























Sargan Test  𝜒2 
(k), (p-value) 
- - 22.33 
(0.17) 
- - 26.000 
(0.21) 




test (AR)  z-
value (p=value) 
   
-0.369 
(0.71) 
   
0.869 
(0.39) 




 Notes: 1) FE- Fixed Effects Model; RE- Random Effects Model; 
LDPD- Linear Dynamic Panel Data Model;    2) t-values are for the FE 
Estimation, and z-values are for the RE and LDPD estimations are shown in 
the parentheses. 
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Table 5: Effectiveness of Public and Private Health Expenditure on Adult Mortality Rates in 
Sub-Saharan Africa Based on Estimates of Linear Dynamic Panel Model 
Corruption Perception Index Mean Min Max 
3 1 6.4 
A.  Effectiveness of Public  Health Expenditure 
ln (public  health expenditure) -0.295 -0.295 -
0.295 
Corruption index*ln (public  health expenditure) 0.195 0.065 0.416 
Net Effect -0.100 -0.230 0.121 
B. Effectiveness of Private  Health Expenditure 
ln (private  health expenditure) 0.269 0.269 0.269 
Corruption index* ln (private  health expenditure) -0.192 -0.064 -
0.410 
Net Effect 0.077 0.192 -
0.141 
Calculations based on estimates in model 3 of Table 4. 
 
Table 6: Regional Differences of Public and Private Health Expenditure, Corruption Effects 
on Adult Mortality Rates (Dependent Variable is ln (Adult Mortality Rates)) 
Independent 
Variables 
Model 4 Model 5 Model 6 
FE RE LDPD FE RE LDPD FE RE LDPD 



























































































































































































































































































































































- - - 
Eastern Africa 
Dummy*corruptio
n index* ln (public  
health 
expenditure) 








n index* ln (public  
health 
expenditure) 








n index* ln (public  
health 
expenditure) 








n index* ln 
(private  health 
expenditure) 








n index* ln 
(private  health 
expenditure) 








n index* ln 
(private  health 
expenditure) 































Number  of 
Observations 
362 362 362 251 251 251 251 251 251 
F-Test, (p-value) 32.64 
(0.00) 
- - 33.00 
(0.00) 
- - 27.15 
(0.00) 
- - 
R-Squared 55.6 54.1 - 72.5 72.2 - 72.4 72.0 - 
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(0.00) (0.00) 









Sargan Test  𝜒2, 
(p-value) 
- - 42.832 
(0.35) 
- - 29.242 
(0.17) 




test (AR)  z-value   
(p=value) 
   
-0.407 
(0.68) 
   
-0.233 
(0.82) 
   
-0.127 
(0.90) 
Notes: 1) FE- Fixed Effects Model; RE- Random Effects Model; LDPD- Linear Dynamic 
Panel Data Model; 2) t-values are for the FE Estimation, and z-values are for the RE and 
LDPD estimations are shown in the parentheses. 
 
Table 7: Regional Differences of Public and Private Health Expenditure and, Corruption 
Effects on Adult Mortality Rates 
Dummy variables for the Region takes the value of 1; 0 otherwise. 
Computation Based on LDPD Estimates 
Model 4a: Regional  Variations  of  Public and Private Health Care Spending 
Southern 
Africa 
Eastern Africa Western Africa Central Africa 
-0.194 -0.121 -0.361 -0.088 
Southern 
Africa 
Eastern Africa Western Africa Central Africa 
0.116 0.067 0.446 0.106 




Eastern Africa Western Africa Central Africa 
-0.179 -0.097 -0.250 0.054 
Southern 
Africa 
Eastern Africa Western Africa Central Africa 
0.155 0.063 0.082 -0.159 
Southern 
Africa 
   
0.407  -0.370 -0.306 
Model 6a: Regional Variations of Public and  Private  Health Spending Efficacy ( 
Interaction  of Regional Dummy with Public and  Private Health Expenditure and 
Corruption); Computed  using CPI  Values at the mean=3 
Southern 
Africa 
Eastern Africa Western Africa Central Africa 
0.159 0.105 -0.046 1.428 
Southern 
Africa 
Eastern Africa Western Africa Central Africa 
-0.164 -0.126 0.165 -0.431 
Source: Author’s Estimations. Note: 1) Mean values of corruption index are extracted from 
the descriptive statistics. 
  
  
